The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China

Roles of Oxidative Stress and Redox Regulation in Atherosclerosis

(2011) Takahito Kondo et al.   Journal of Atherosclerosis and Thrombosis

Estrogens and Development of Pulmonary Hypertension: Interaction of Estradiol Metabolism and Pulmonary Vascular Disease

(2010) Stevan P Tofovic   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Impact ofCYP2C8and2C9polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort

(2010) Elisabeth Haschke-Becher et al.   PHARMACOGENOMICS

Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases

(2010) Beshay N.M. Zordoky et al.   PHARMACOLOGY & THERAPEUTICS

Oxidation of Endobiotics Mediated by Xenobiotic-Metabolizing Forms of Human Cytochrome P450

(2009) Toshiro Niwa et al.   CURRENT DRUG METABOLISM

Polymorphisms of cytochrome P450 1A1, cigarette smoking and risk of coronary artery disease

(2009) Chih-Ching Yeh et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52 000 individuals

(2009) D Kaur-Knudsen et al.   PHARMACOGENOMICS JOURNAL

Transradial versus transfemoral approach for percutaneous coronary procedures

(2009) Elena Franchi et al.   Current Cardiology Reports

Modulation of Cardiac and Hepatic Cytochrome P450 Enzymes During Heart Failure

(2008) Ayman El-Kadi et al.   CURRENT DRUG METABOLISM